Pulmonx (LUNG) Change in Account Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Account Payables data on file, last reported at $121000.0 in Q3 2025.

• On a quarterly basis, Change in Account Payables fell 91.02% year-over-year to $121000.0 in Q3 2025; TTM through Sep 2025 was $2.1 million, a 61.41% increase from a year earlier, with the FY2024 full-year figure at $2.3 million, up 760.29% from the prior year.
• Change in Account Payables for Q3 2025 stood at $121000.0, down from $2.1 million in the prior quarter.
• Over the last five years, Change in Account Payables for LUNG reached as high as $2.6 million in Q3 2021 and fell as low as -$2.8 million in Q4 2021.
• Historically, Change in Account Payables has averaged $264894.7 across 5 years, with a median of $121000.0 in 2025.
• Across the five-year window, Change in Account Payables plunged 2111.11% in 2022 and surged 42900.0% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at -$2.8 million in 2021, then surged by 70.54% to -$830000.0 in 2022, then sank by 104.58% to -$1.7 million in 2023, then jumped by 58.78% to -$700000.0 in 2024, then surged by 117.29% to $121000.0 in 2025.
• Per Business Quant data, the three most recent Change in Account Payables figures were $121000.0 in Q3 2025, $2.1 million in Q2 2025, and $505000.0 in Q1 2025.